Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

COUR Pharmaceutical Development Company, Inc.

Clinical trials sponsored by COUR Pharmaceutical Development Company, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to control type 1 diabetes early Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug aims to control type 1 diabetes early

Disease control Recruiting now

This study tests a new drug, CNP-103, in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either the drug or a placebo, and researchers…

Phase 1/2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC